Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)
The purpose of this study is to evaluate the long-term safety and efficacy of the Xact? Rapid Exchange Carotid Stent System used in conjunction with the Emboshield® Pro Rapid Exchange Embolic Protection System (Generation 5) and the Emboshield® BareWire? Rapid Exchange Embolic Protection System (Generation 3), in the treatment of atherosclerotic carotid artery disease in high-surgical risk subjects.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- device : Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3)
Ages Eligible For Study: